ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p461.xmlMisdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic TP53 Mutation2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p461.pdf2026-04-18Misdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic TP53 Mutationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p458.xmlPACIFIC: An Ocean of Hope in Patients With Stage III Unresectable Non–Small Cell Lung Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p458.pdf2026-04-18PACIFIC: An Ocean of Hope in Patients With Stage III Unresectable Non–Small Cell Lung Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p457.xmlGetting Into the Weeds2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p457.pdf2026-04-18Getting Into the Weedshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-pxlvii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-pxlvii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-pxxx.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-pxxx.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p467.xmlRediagnosis of Lung Cancer as NUT Midline Carcinoma Based on Clues From Tumor Genomic Profiling2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p467.pdf2026-04-18Rediagnosis of Lung Cancer as NUT Midline Carcinoma Based on Clues From Tumor Genomic Profilinghttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p473.xmlRedefining Quality Measurement in Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p473.pdf2026-04-18Redefining Quality Measurement in Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p536.xmlSoft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p536.pdf2026-04-18Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p498.xmlDances With Denial: Have Medical Oncology Outpatients Conveyed Their End-of-Life Wishes and Do They Want To?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p498.pdf2026-04-18Dances With Denial: Have Medical Oncology Outpatients Conveyed Their End-of-Life Wishes and Do They Want To?https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p526.xmlAdherence to Guidelines for Breast Surveillance in Breast Cancer Survivors2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p526.pdf2026-04-18Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivorshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p508.xmlSequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non–Small Cell Lung Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p508.pdf2026-04-18Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non–Small Cell Lung Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p518.xmlGenetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p518.pdf2026-04-18Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p479.xmlNCCN Guidelines Insights: Head and Neck Cancers, Version 1.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p479.pdf2026-04-18NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p491.xmlEffectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p491.pdf2026-04-18Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosishttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p564.xmlRole of Molecular Profiling in Soft Tissue Sarcoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p564.pdf2026-04-18Role of Molecular Profiling in Soft Tissue Sarcomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p572.xmlA Small Step Closer But Not Yet There: Oral Anti-Xa Agents and the Treatment of Cancer-Associated Venous Thromboembolism2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5/article-p572.pdf2026-04-18A Small Step Closer But Not Yet There: Oral Anti-Xa Agents and the Treatment of Cancer-Associated Venous Thromboembolismhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p594.xmlNew NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicity2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p594.pdf2026-04-18New NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicityhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p582.xmlAbstracts From the NCCN 23rdAnnual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p582.pdf2026-04-18Abstracts From the NCCN 23rdAnnual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p575.xmlThe NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p575.pdf2026-04-18The NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p617.xmlManagement of Locoregional Rectal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p617.pdf2026-04-18Management of Locoregional Rectal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p605.xmlNCCN Guidelines Updates: Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p605.pdf2026-04-18NCCN Guidelines Updates: Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p611.xmlOptimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p611.pdf2026-04-18Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p601.xmlTargeted Therapy for Patients With Metastatic Non–Small Cell Lung Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p601.pdf2026-04-18Targeted Therapy for Patients With Metastatic Non–Small Cell Lung Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p597.xmlNew NCCN Guidelines: Cancer Management in People Living With HIV2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p597.pdf2026-04-18New NCCN Guidelines: Cancer Management in People Living With HIVhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p620.xmlNCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p620.pdf2026-04-18NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detectionhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p651.xmlEmerging Treatment Options for Acute Lymphoblastic Leukemia: Focus on CAR T-Cell Therapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p651.pdf2026-04-18Emerging Treatment Options for Acute Lymphoblastic Leukemia: Focus on CAR T-Cell Therapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p646.xmlNew NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p646.pdf2026-04-18New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p642.xmlRole of Molecular Pathology in the Treatment of Anaplastic Gliomas and Glioblastomas2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p642.pdf2026-04-18Role of Molecular Pathology in the Treatment of Anaplastic Gliomas and Glioblastomashttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p636.xmlThe Changing Treatment Landscape for Metastatic Urothelial Carcinoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p636.pdf2026-04-18The Changing Treatment Landscape for Metastatic Urothelial Carcinomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p639.xmlUpdates to the Management of Kidney Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p639.pdf2026-04-18Updates to the Management of Kidney Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p656.xmlPrognostic Significance of Molecular Markers and Targeted Regimens in the Management of Acute Myeloid Leukemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p656.pdf2026-04-18Prognostic Significance of Molecular Markers and Targeted Regimens in the Management of Acute Myeloid Leukemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p632.xmlNew Therapies for Ovarian Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p632.pdf2026-04-18New Therapies for Ovarian Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p624.xmlManagement of Multiple Myeloma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p624.pdf2026-04-18Management of Multiple Myelomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p628.xmlNCCN Frameworks for Resource Stratification of NCCN Guidelines: Adult Cancer Pain and Palliative Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p628.pdf2026-04-18NCCN Frameworks for Resource Stratification of NCCN Guidelines: Adult Cancer Pain and Palliative Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p666.xmlHead and Neck Cancers: Advantages of Advanced Radiation Therapy and Importance of Supportive Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p666.pdf2026-04-18Head and Neck Cancers: Advantages of Advanced Radiation Therapy and Importance of Supportive Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p663.xmlHepatocellular Carcinoma: Updates to Screening and Diagnosis2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p663.pdf2026-04-18Hepatocellular Carcinoma: Updates to Screening and Diagnosishttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p660.xmlPregnancy in Patients With Chronic Myeloid Leukemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p660.pdf2026-04-18Pregnancy in Patients With Chronic Myeloid Leukemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-pe-1.xmlAbstracts From the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-pe-1.pdf2026-04-18Abstracts From the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p670.xmlUse of Direct Oral Anticoagulants for Treating Venous Thromboembolism in Patients With Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/5S/article-p670.pdf2026-04-18Use of Direct Oral Anticoagulants for Treating Venous Thromboembolism in Patients With Cancer